Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease

Parkinsonism and Related Disorders

Volumn 28, Issue , 2016, Pages 137-140

  Erro, Roberto ^a,b   Picillo, Marina ^c   Vitale, Carmine ^d,e   Palladino, Raffaele ^f   Amboni, Marianna ^e   Moccia, Marcello ^g   Pellecchia, Maria Teresa ^c   Barone, Paolo ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VERONA   (Italy)

^c UNIVERSITY OF SALERNO   (Italy)

^d UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^e IDC Hermitage Capodimonte   (Italy)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Clusters; Heterogeneity; Non motor; Parkinson; Subtypes

Indexed keywords

RADIOPHARMACEUTICAL AGENT;

ADULT; AGE DISTRIBUTION; APATHY; ARTICLE; BINDING AFFINITY; BRAIN REGION; CLUSTER ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; DOPAMINERGIC SYSTEM; FEMALE; GERIATRIC DEPRESSION SCALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTREAL COGNITIVE ASSESSMENT; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; REM SLEEP BEHAVIOR DISORDER QUESTIONNAIRE; SCALES FOR OUTCOMES IN PARKINSON DISEASE AUTONOMIC; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATE TRAIT ANXIETY INVENTORY FOR ADULT; UNIVERSITY OF PENNSYLVANIA SMELL IDENTIFICATION TEST; AGED; CLASSIFICATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

AGED; CLUSTER ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84964716253     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2016.04.026     Document Type: Article

References (12)

1. Marras C. Subtypes of Parkinson's disease: state of the field and future directions. Curr. Opin. Neurol. 2015, 28:382-386.
2. Zis P., Erro R., Walton C.C., Sauerbier A., Ray Chaudhuri K. The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review. Nat. Parkinson's J. (NPJ) Parkinson's Dis. 2015, 15013.
3. Erro R., Vitale C., Amboni M., Picillo M., Moccia M., Longo K., et al. The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. PloS One 2013, 8:e70244.
4. Pont-Sunyer C., Hotter A., Gaig C., Seppi K., Compta Y., Katzenschlager R., et al. The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study). Mov. Disord. 2015, 30:229-237.
5. Fereshtehnejad S.M., Romenets S.R., Anang J.B., Latreille V., Gagnon J.F., Postuma R.B. New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes. JAMA Neurol. 2015, 72:863-873.
6. Lawton M., Baig F., Rolinski M., Ruffman C., Nithi K., May M.T., et al. Parkinson's disease subtypes in the Oxford Parkinson disease centre (OPDC) discovery cohort. J. Park. Dis. 2015, 5:269-279.
7. Zis P., Martinez-Martin P., Sauerbier A., Rizos A., Sharma J.C., Worth P.F., et al. Non-motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non-motor subtypes. Eur. J. Neurol. 2015, 22:1145-1150.
8. Erro R., Picillo M., Amboni M., Moccia M., Vitale C., Longo K., et al. Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease. Mov. Disord. 2015, 30:373-378.
9. Erro R., Picillo M., Vitale C., Amboni M., Moccia M., Longo K., et al. Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. J. Neurol. Neurosurg. Psychiatry 2013, 84:14-17.
10. Lewis S.J., Foltynie T., Blackwell A.D., Robbins T.W., Owen A.M., Barker R.A. Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. J. Neurol. Neurosurg. Psychiatry 2005, 76:343-348.
11. 123I]FP-CIT binding in the caudate nucleus. J. Neurol. Neurosurg. Psychiatry 2014, 85:159-164.
12. Santangelo G., Vitale C., Picillo M., Moccia M., Cuoco S., Longo K., et al. Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study. Park. Relat. Disord. 2015, 21:1219-1226.